✦ LIBER ✦

Benefit of Allogeneic Transplantation in Patients Age ≥ 60 Years with Acute Myeloid Leukemia Is Limited to Those in First Complete Remission at Time of Transplant

✍ Scribed by Michelis, Fotios V.; Messner, Hans A.; Atenafu, Eshetu G.; Kim, Dennis D.; Kuruvilla, John; Lipton, Jeffrey H.; Uhm, Jieun; Loach, David; Gupta, Vikas

Book ID: 121843876
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 391 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.560

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogenic bone marrow transplantation of

Allogenic bone marrow transplantation of chemotherapy for patients with acute myeloid leukemia in first complete remission: a decision analysis approach

✍ B. Hertenstein; G. Heil; H. Heimpel 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 180 KB

Frequency of Allogeneic Hematopoietic Ce

Frequency of Allogeneic Hematopoietic Cell Transplantation Among Patients With High- or Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission

✍ Mawad, R.; Gooley, T. A.; Sandhu, V.; Lionberger, J.; Scott, B.; Sandmaier, B. M 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 121 KB

Reduced intensity conditioning prior to

Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype

✍ Philipp G. Hemmati; Theis H. Terwey; Gero Massenkeil; Philipp le Coutre; Lam G. 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 243 KB

Autologous and allogeneic bone marrow tr

Autologous and allogeneic bone marrow transplantation in acute myeloid leukemia in first complete remission: an update of the Genoa experience with 159 patients

✍ A. M. Carella; F. Frassoni; M. T. van Lint; F. Gualandi; D. Occhini; P. Carlier; 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 318 KB

Comparison of Reduced-Intensity Hematopo

Comparison of Reduced-Intensity Hematopoietic Cell Transplantation with Chemotherapy in Patients Age 60-70 Years with Acute Myelogenous Leukemia in First Remission

✍ Sherif S. Farag; Kati Maharry; Mei-Jie Zhang; Waleska S. Pérez; Stephen L. Georg 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Idarubicin to intensify the conditioning

Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission

✍ Jerjis, Sh; Roovers, E; Muus, P; Schaap, N; de Witte, T 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 68 KB